Related Experiment Video
Updated: May 5, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
Endocannabinoid signals in the developmental programming of delayed-onset neuropsychiatric and metabolic illnesses
Erik Keimpema1, Daniela Calvigioni, Tibor Harkany
1*Division of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Scheeles väg 1:A1, Karolinska Institutet, SE-17177 Stockholm, Sweden.
Abstract:
It is increasingly recognized that maternal exposure to metabolic (nutritional) stimuli, infections, illicit or prescription drugs and environmental stressors during pregnancy can predispose affected offspring to developing devastating postnatal illnesses. If detrimental maternal stimuli coincide with critical periods of tissue production and organogenesis then they can permanently derail key cellular differentiation programs. Maternal programming can thus either provoke developmental failure directly ('direct hit') or introduce latent developmental errors that enable otherwise sub-threshold secondary stressors to manifest as disease ('double hit') postnatally. Accumulating evidence suggests that nervous system development is tightly controlled by maternal metabolic stimuli, and whose synaptic wiring and integrative capacity are adversely affected by dietary and hormonal challenges, infections or episodes of illicit drug use. Endocannabinoids, a family of signal lipids derived from polyunsaturated fatty acids, have been implicated in neuronal fate determination, the control of axonal growth, synaptogenesis and synaptic neurotransmission. Therefore the continuum and interdependence of endocannabinoid actions during the formation and function of synapses together with dynamic changes in focal and circulating endocannabinoid levels upon maternal nutritional imbalance suggest that endocannabinoids can execute the 'reprogramming' of specific neuronal networks. In the present paper, we review molecular evidence suggesting that maternal nutrition and metabolism during pregnancy can affect the formation and function of the hippocampus and hypothalamus by altering endocannabinoid signalling such that neuropsychiatric diseases and obesity respectively ensue in affected offspring. Moreover, we propose that the placenta, fetal adipose and nervous tissues interact via endocannabinoid signals. Thus endocannabinoids are hypothesized to act as a molecular substrate of maternal programming.
Insights
Maternal nutrition during pregnancy impacts offspring brain development and function via endocannabinoids. This molecular signaling pathway influences the risk of neuropsychiatric diseases and obesity in children.
Area of Science:
- Neuroscience
- Developmental Biology
- Endocrinology
Background:
- Maternal exposures during pregnancy can lead to offspring illnesses.
- Nervous system development is sensitive to maternal metabolic and environmental factors.
- Endocannabinoids are key lipid mediators in neuronal development and function.
Purpose of the Study:
- To review molecular evidence on how maternal nutrition affects offspring brain development.
- To explore the role of endocannabinoids in mediating maternal programming.
- To investigate the link between maternal metabolism, endocannabinoids, and postnatal diseases.
Main Methods:
- Review of molecular evidence on maternal programming.
- Analysis of endocannabinoid signaling in neurodevelopment.
- Examination of the interplay between maternal factors, endocannabinoids, and offspring health outcomes.
Main Results:
- Maternal nutrition and metabolism alter endocannabinoid signaling.
- Altered endocannabinoid signaling affects hippocampus and hypothalamus development.
- This reprogramming is linked to neuropsychiatric diseases and obesity in offspring.
Conclusions:
- Endocannabinoids act as a molecular substrate for maternal programming.
- Placenta, fetal adipose, and nervous tissues interact via endocannabinoid signals.
- Maternal metabolic status critically influences offspring neurodevelopment and disease susceptibility through endocannabinoid pathways.
More Related Videos
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
14:25Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
Published on: September 21, 2019
Related Concept Videos
Gut-Brain Axis
Regulation of Food Intake
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids